Form 4 holding
SVP AND CFO
Celldex Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 32,942
- Estimated value
- $341,937
- Report date
- 02 Jan 2026
- Price
- $10.38
- Ownership
- Direct
Samuel Bates Martin - SVP AND CFO at Celldex Therapeutics, Inc.
Issuer-level insider activity
- Role
- Svp And Cfo
- Issuer ticker
- CLDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Samuel Bates Martin since 03 Aug 2025
Reported holdings for Samuel Bates Martin in Celldex Therapeutics, Inc.
Form 4 holding
SVP AND CFO
Celldex Therapeutics, Inc.
- Security class
- Incentive Stock Option (right to buy)
- Shares / value
- 93,000
- Estimated value
- Report date
- 25 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Samuel Bates Martin in Celldex Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.